However, one study found that METTL3 acts as a tumor suppressor gene in CRC proliferation and metastasis by inhibiting the activation of the p38/ERK pathway.[43] The cancer heterogeneity and different downstream genes might be the reasons to explain the different roles of METTL3 in CRC. The gene discussed is METTL3; the disease is neoplasm.